Results 141 to 150 of about 1,109,342 (353)

A Midsummer Night\u27s Dream Poster [PDF]

, 2016
Providence College Department of Theatre, Dance & Film John Bowab Studio Theatre A Midsummer Night\u27s Dream By William Shakespeare April 8-10 & 14-17https://digitalcommons.providence.edu/midsummer_pubs/1000/thumbnail ...
Providence College
core   +1 more source

Karen Collins (Ed.): From pac-man to pop music. Interactive audio in games and new media. Hampshire: Ashgate Publishing, 2008

MedieKultur: Journal of Media and Communication Research, 2010
Vitus Vestergaard
doaj   +3 more sources

Riding High in Pendleton [PDF]

, 2006
With an effervescent smile, the graceful wave of a hand and lots of hooting and hollering, Darlene Thompson ’07 fulfilled a lifelong dream this ...
Davis, Laura
core   +1 more source

A Phase 1, Randomized, Placebo‐Controlled, Multiple‐Dose, Double‐Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals

Clinical Pharmacology in Drug Development, EarlyView.
Abstract This Phase 1, randomized, placebo‐controlled, double‐blind study assessed the pharmacokinetic profile of rimegepant (25, 75, or 150 mg once daily for 14 days) in healthy Japanese and Caucasian adults. Exposures were modestly increased in Japanese participants compared with Caucasian participants following a single dose of rimegepant (Day 1 ...
Rajinder Bhardwaj, Chay Ngee Lim, Yinhua Li, Kyle T. Matschke, Richard Bertz, Robert Croop, Jing Liu   +6 more
wiley   +1 more source

Poverty in the New World Dream: Families and Gender in Southern Dunedin, New Zealand, 1890-1920

, 2004
Annabel Cooper, Marian Horan
openalex   +2 more sources

PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature

Clinical Pharmacology &Therapeutics, EarlyView.
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou, Estella S. Poloni, José A.G. Agúndez, Raquel L.F. Teixeira, Erin C. Boone, Adalberto Rezende Santos, Michelle Whirl‐Carrillo, Katrin Sangkuhl, Teri E. Klein, Mariam R. Habil, Giannoulis Fakis, Rodney F. Minchin, David W. Hein, Sotiria Boukouvala, Andrea Gaedigk   +14 more
wiley   +1 more source

EVALUATING THE CREDIT RISK MANAGEMENT PRACTICES OF MICROFINANCE INSTITUTIONS IN GHANA: EVIDENCE FROM CAPITAL LINE INVESTMENT LTD. AND DREAM FINANCE LTD.

, 2016
Ransford Quarmyne Churchill
openalex   +1 more source

Nuestra Comunidad: The Role of Latin American Networks in Supporting Ecologists Throughout Their Careers

The Bulletin of the Ecological Society of America, EarlyView.
Shersingh Joseph Tumber‐Dávila, Angelique Rosa Marín, Rodrigo Felipe Rodrigues do Carmo, Sergio González‐Mollinedo, Luis Y. Santiago‐Rosario, Coral del Mar Valle Rodríguez   +5 more
wiley   +1 more source

Straight to Phase III: Model‐Informed Approach Speeds Depemokimab Clinical Development in Interleukin‐5‐Driven Diseases

Clinical Pharmacology &Therapeutics, EarlyView.
Straight to Phase III: Model‐informed approach speeds depemokimab clinical development in interleukin‐5‐driven diseases. IL‐5, a key mediator of type 2 inflammation, underlies various diseases, including severe asthma, CRSwNP, EGPA, and HES. Reduction in blood eosinophil count (BEC), a biomarker of IL‐5 activity, is commonly used to evaluate the ...
Chiara Zecchin, Stein Schalkwijk, Isabelle J. Pouliquen, Alienor Berges, Nicholas Bird, Richard Follows, Daren Austin   +6 more
wiley   +1 more source

DREAMS Toolchain: Model-Driven Engineering of Mixed-Criticality Systems

, 2017
Simon Barner, Alexander Diewald, Jörn Migge, Ali Syed, Gerhard Fohler, Madeleine Faugère, Daniel Gracia Pérez   +6 more
openalex   +2 more sources